New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 25, 2014
07:59 EDTEVHC, BKD, CYH, AFAM, HCA, CTRX, ACHCSome healthcare providers offer compelling opportunities, says Jefferies
Jefferies believes that the following healthcare providers reported good Q2 results which have not been adequately reflected by their stocks: Acadia Healthcare (ACHC), Almost Family (AFAM), Brookdale Senior Living (BKD), Catamaran (CTRX), Community Health (CYH), Envision Healthcare (EVHC), and HCA Holdings (HCA). The firm expects the sector as a whole to continue to improve in 2H14 amid continued tailwinds from healthcare reform.
News For ACHC;AFAM;BKD;CTRX;CYH;EVHC;HCA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 20, 2014
07:15 EDTACHC, HCAAmerican Academy of Child & Adolescent Psychiatry to hold annual meeting
Subscribe for More Information
October 16, 2014
15:10 EDTCYHAmerican College of Gastroenterology to hold annual meeting
ACG Annual Scientific Meeting 2014 to be held in Philadlephia, PA on October 17-22.
09:23 EDTHCAOn The Fly: Pre-market Movers
Subscribe for More Information
October 15, 2014
18:26 EDTHCAOn The Fly: After Hours Movers
Subscribe for More Information
17:57 EDTHCAHCA Holdings up 7.5% following preliminary Q3 earnings, raised guidance
16:57 EDTHCAHCA Holdings raises FY14 revenue guidance to $36.5B-$37.0B from $36.0B-$36.5B
Subscribe for More Information
16:54 EDTHCAHCA Holdings reports preliminary Q3 EPS $1.16, consensus 98c
Subscribe for More Information
October 13, 2014
08:03 EDTCYHCommunity Health to divest Harsville, SC hospital to Capella Healthcare
Subscribe for More Information
07:39 EDTCTRXPharmaceutical Care Management Association to hold annual meeting
Subscribe for More Information
October 10, 2014
08:56 EDTHCAHCA Holdings outlook positive, says RBC Capital
Subscribe for More Information
07:29 EDTEVHCEnvision Healthcare pullback a 'compelling' opportunity, says Jefferies
Jefferies views the recent pullback in shares of Envision Healthcare as a "compelling" buying opportunity. The firm believes shares can now trade on fundamentals and move back to $40 with the secondary offering overhang out of the way. It keeps a Buy rating on Envision with a $40 price target.
October 9, 2014
09:12 EDTCTRXCatamaran acquisition in-line with expectations, says Leerink
Subscribe for More Information
07:37 EDTCTRXCatamaran acquisition likely to be well-received, says Oppenheimer
Subscribe for More Information
October 8, 2014
16:34 EDTCTRXCatamaran to acquire Salveo Specialty Pharmacy for $260M in cash
Catamaran announced that it has entered into a definitive agreement to acquire Salveo Specialty Pharmacy, an independent specialty pharmacy company headquartered in St. Petersburg, Florida with business operations in New York and California. Salveo manages approximately $400M in annual drug spend. The purchase price of $260M in cash represents a purchase price multiple of approximately 13x Salveo's trailing-twelve-month EBITDA and is expected to be funded through cash on the balance sheet. This acquisition is expected to be completed during Q4.
October 7, 2014
06:03 EDTCYH, HCACMS readmission penalties increase in 2015, says Wells Fargo
Wells Fargo says CMS released the final 2015 IPPS payment penalties for hospital readmissions, with incremental earnings Impact of down 0.2% to down 1.9% at for-profit hospitals. The firm estimates Community Health Systems (CYH) and Tenet Health (THC) will see the largest incremental reimbursement reduction in 2015, equal to down 1.9% and down 1.4%, respectively. It notes 2015 is the third year of hospital readmission penalties with a maximum penalty of 3%, up from 2% in 2014 and 1% in 2013. Wells has Outperform ratings on Community Health and HCA Holdings (HCA), and Market Perform ratings on LifePoint Hospitals (LPNT), Tenet and Universal Health (UHS).

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use